Global Organoids Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:

Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.

Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.

Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.

According to APO Research, The global Organoids market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Organoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Organoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Organoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Organoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Organoids include Thermo Fisher Scientific, Merck, Corning, STEMCELL Technologies, Lonza, Prellis Biologics, amsbio, Cellesce and DefiniGEN, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Organoids, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Organoids, also provides the revenue of main regions and countries. Of the upcoming market potential for Organoids, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Organoids revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Organoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Organoids revenue, projected growth trends, production technology, application and end-user industry.


Organoids Segment by Company

Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero

Organoids Segment by Type

3D Organoid Culture
Biochemical Cues

Organoids Segment by Application

Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes

Organoids Segment by Region

North America

United States

Canada

Mexico
Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland
Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia
South America

Brazil

Argentina

Chile

Colombia
Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Organoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organoids industry.
Chapter 3: Detailed analysis of Organoids companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organoidsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Organoids Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 3D Organoid Culture
1.2.3 Biochemical Cues
1.3 Market Analysis by Application
1.3.1 Global Organoids Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Research Organizations
1.3.4 Academics and Research Institutes
1.4 Global Market Growth Prospects
1.5 Global Organoids Growth Trends by Region
1.5.1 Global Organoids Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Organoids Market Size by Region (2020-2025)
1.5.3 Organoids Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Organoids Market Dynamics
2.1 Organoids Industry Trends
2.2 Organoids Industry Drivers
2.3 Organoids Industry Opportunities and Challenges
2.4 Organoids Industry Restraints
3 Competitive Landscape by Company
3.1 Global Organoids Revenue by Company (2020-2025)
3.2 Global Organoids Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Organoids Key Company Head office and Area Served
3.4 Global Organoids Company, Product Type & Application
3.5 Global Organoids Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Organoids Market CR5 and HHI
3.6.2 Global Top 5 and 10 Organoids Players Market Share by Revenue in 2024
3.6.3 2024 Organoids Tier 1, Tier 2, and Tier 3
4 Organoids Market by Type
4.1 Global Organoids Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Organoids Market Size by Type (2020-2031)
4.3 Global Organoids Market Size Share by Type (2020-2031)
5 Organoids Market by Application
5.1 Global Organoids Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Organoids Market Size by Application (2020-2031)
5.3 Global Organoids Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Comapny Information
6.1.2 Thermo Fisher Scientific Business Overview
6.1.3 Thermo Fisher Scientific Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Thermo Fisher Scientific Organoids Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments
6.2 Merck
6.2.1 Merck Comapny Information
6.2.2 Merck Business Overview
6.2.3 Merck Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Merck Organoids Product Portfolio
6.2.5 Merck Recent Developments
6.3 Corning
6.3.1 Corning Comapny Information
6.3.2 Corning Business Overview
6.3.3 Corning Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Corning Organoids Product Portfolio
6.3.5 Corning Recent Developments
6.4 STEMCELL Technologies
6.4.1 STEMCELL Technologies Comapny Information
6.4.2 STEMCELL Technologies Business Overview
6.4.3 STEMCELL Technologies Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 STEMCELL Technologies Organoids Product Portfolio
6.4.5 STEMCELL Technologies Recent Developments
6.5 Lonza
6.5.1 Lonza Comapny Information
6.5.2 Lonza Business Overview
6.5.3 Lonza Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Lonza Organoids Product Portfolio
6.5.5 Lonza Recent Developments
6.6 Prellis Biologics
6.6.1 Prellis Biologics Comapny Information
6.6.2 Prellis Biologics Business Overview
6.6.3 Prellis Biologics Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Prellis Biologics Organoids Product Portfolio
6.6.5 Prellis Biologics Recent Developments
6.7 amsbio
6.7.1 amsbio Comapny Information
6.7.2 amsbio Business Overview
6.7.3 amsbio Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 amsbio Organoids Product Portfolio
6.7.5 amsbio Recent Developments
6.8 Cellesce
6.8.1 Cellesce Comapny Information
6.8.2 Cellesce Business Overview
6.8.3 Cellesce Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Cellesce Organoids Product Portfolio
6.8.5 Cellesce Recent Developments
6.9 DefiniGEN
6.9.1 DefiniGEN Comapny Information
6.9.2 DefiniGEN Business Overview
6.9.3 DefiniGEN Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 DefiniGEN Organoids Product Portfolio
6.9.5 DefiniGEN Recent Developments
6.10 OcellO B.V.
6.10.1 OcellO B.V. Comapny Information
6.10.2 OcellO B.V. Business Overview
6.10.3 OcellO B.V. Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 OcellO B.V. Organoids Product Portfolio
6.10.5 OcellO B.V. Recent Developments
6.11 HUB Oranoid Technology
6.11.1 HUB Oranoid Technology Comapny Information
6.11.2 HUB Oranoid Technology Business Overview
6.11.3 HUB Oranoid Technology Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.11.4 HUB Oranoid Technology Organoids Product Portfolio
6.11.5 HUB Oranoid Technology Recent Developments
6.12 3Dnamics Inc.
6.12.1 3Dnamics Inc. Comapny Information
6.12.2 3Dnamics Inc. Business Overview
6.12.3 3Dnamics Inc. Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.12.4 3Dnamics Inc. Organoids Product Portfolio
6.12.5 3Dnamics Inc. Recent Developments
6.13 Organoid Therapeutics
6.13.1 Organoid Therapeutics Comapny Information
6.13.2 Organoid Therapeutics Business Overview
6.13.3 Organoid Therapeutics Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.13.4 Organoid Therapeutics Organoids Product Portfolio
6.13.5 Organoid Therapeutics Recent Developments
6.14 InSphero
6.14.1 InSphero Comapny Information
6.14.2 InSphero Business Overview
6.14.3 InSphero Organoids Revenue and Gross Margin (US$ Million) & (2020-2025)
6.14.4 InSphero Organoids Product Portfolio
6.14.5 InSphero Recent Developments
7 North America
7.1 North America Organoids Market Size (2020-2031)
7.2 North America Organoids Market Size by Type
7.2.1 North America Organoids Market Size by Type (2020-2025)
7.2.2 North America Organoids Market Size by Type (2026-2031)
7.2.3 North America Organoids Market Share by Type (2020-2031)
7.3 North America Organoids Market Size by Application
7.3.1 North America Organoids Market Size by Application (2020-2025)
7.3.2 North America Organoids Market Size by Application (2026-2031)
7.3.3 North America Organoids Market Share by Application (2020-2031)
7.4 North America Organoids Market Size by Country
7.4.1 North America Organoids Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Organoids Market Size by Country (2020-2025)
7.4.3 North America Organoids Market Size by Country (2026-2031)
7.4.4 North America Organoids Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Organoids Market Size (2020-2031)
8.2 Europe Organoids Market Size by Type
8.2.1 Europe Organoids Market Size by Type (2020-2025)
8.2.2 Europe Organoids Market Size by Type (2026-2031)
8.2.3 Europe Organoids Market Share by Type (2020-2031)
8.3 Europe Organoids Market Size by Application
8.3.1 Europe Organoids Market Size by Application (2020-2025)
8.3.2 Europe Organoids Market Size by Application (2026-2031)
8.3.3 Europe Organoids Market Share by Application (2020-2031)
8.4 Europe Organoids Market Size by Country
8.4.1 Europe Organoids Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Organoids Market Size by Country (2020-2025)
8.4.3 Europe Organoids Market Size by Country (2026-2031)
8.4.4 Europe Organoids Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Organoids Market Size (2020-2031)
9.2 China Organoids Market Size by Type
9.2.1 China Organoids Market Size by Type (2020-2025)
9.2.2 China Organoids Market Size by Type (2026-2031)
9.2.3 China Organoids Market Share by Type (2020-2031)
9.3 China Organoids Market Size by Application
9.3.1 China Organoids Market Size by Application (2020-2025)
9.3.2 China Organoids Market Size by Application (2026-2031)
9.3.3 China Organoids Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Organoids Market Size (2020-2031)
10.2 Asia Organoids Market Size by Type
10.2.1 Asia Organoids Market Size by Type (2020-2025)
10.2.2 Asia Organoids Market Size by Type (2026-2031)
10.2.3 Asia Organoids Market Share by Type (2020-2031)
10.3 Asia Organoids Market Size by Application
10.3.1 Asia Organoids Market Size by Application (2020-2025)
10.3.2 Asia Organoids Market Size by Application (2026-2031)
10.3.3 Asia Organoids Market Share by Application (2020-2031)
10.4 Asia Organoids Market Size by Country
10.4.1 Asia Organoids Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Organoids Market Size by Country (2020-2025)
10.4.3 Asia Organoids Market Size by Country (2026-2031)
10.4.4 Asia Organoids Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Organoids Market Size (2020-2031)
11.2 South America, Middle East & Africa Organoids Market Size by Type
11.2.1 South America, Middle East & Africa Organoids Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Organoids Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Organoids Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Organoids Market Size by Application
11.3.1 South America, Middle East & Africa Organoids Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Organoids Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Organoids Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Organoids Market Size by Country
11.4.1 South America, Middle East & Africa Organoids Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Organoids Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Organoids Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Organoids Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings